Design Therapeutics, Inc. (DSGN) Free cash flow 2020–2025
Design Therapeutics, Inc. (DSGN) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$54.6MFY2025 · since FY2020: -$8.7M → -$54.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$54.6M | -25.6% |
| FY2024 | -$43.4M | +26.1% |
| FY2023 | -$58.8M | -12.6% |
| FY2022 | -$52.2M | -69.0% |
| FY2021 | -$30.9M | -253.5% |
| FY2020 | -$8.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More DSGN financial trends
DSGN RevenueDSGN Net incomeDSGN Net marginDSGN Gross profitDSGN Gross marginDSGN Operating incomeDSGN Operating marginDSGN Operating cash flowDSGN Capital expendituresDSGN Return on equityDSGN Stock buybacksDSGN Dividends paidDSGN Total assetsDSGN Total liabilitiesDSGN Shareholders’ equityDSGN overview →